Scottish Brain Sciences conducts research on neurodegenerative diseases, utilizing advanced diagnostic methods to enhance early detection and treatment of conditions like Alzheimer's disease. By offering free brain health assessments and participation in longitudinal studies, the company aims to improve patient outcomes and contribute to the understanding of brain health over time.
Funding
Funding not disclosed
Founders
Product
Problem
Early detection and effective treatment of neurodegenerative diseases like Alzheimer's are hindered by a lack of accessible and advanced diagnostic methods. This results in delayed intervention and reduced opportunities to improve patient outcomes.
Solution
Scottish Brain Sciences accelerates the development and implementation of new diagnostics and therapeutics for Alzheimer’s disease and other related conditions through research. The company offers brain health checks to test memory, thinking skills, and physical wellbeing, and conducts longitudinal studies to track brain health over time. Scottish Brain Sciences also delivers clinical trials of new active immunotherapies, such as vaccines, aimed at preventing or slowing the progression of Alzheimer's Disease. By detecting elevated levels of proteins like amyloid and tau, which are associated with the pre-symptomatic phase of Alzheimer’s, Scottish Brain Sciences supports early intervention.
Target Audience
The primary audience includes individuals concerned about their memory or diagnosed with brain conditions such as mild cognitive impairment or Alzheimer’s disease, as well as clinical researchers and the broader life sciences community.
Features
- Free brain health checks to assess memory, thinking skills, and physical wellbeing
- Longitudinal studies to track brain health changes over time
- Clinical trials for new Alzheimer's treatments, including active immunotherapies (vaccines)
- Blood and spinal fluid tests to detect early-stage Alzheimer's indicators
- Brain scans to identify elevated levels of amyloid and tau proteins
- Collaboration with universities, the NHS, and other life sciences companies